within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EC04_Balsalazide;

model Balsalazide
  extends Pharmacolibrary.Drugs.ATC.A.A07EC04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Balsalazide</td></tr><tr><td>ATC code:</td><td>A07EC04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Balsalazide is an anti-inflammatory drug belonging to the class of aminosalicylates, used primarily in the treatment of mild-to-moderate ulcerative colitis. It is a prodrug that releases mesalazine (5-aminosalicylic acid, 5-ASA) in the colon. Balsalazide is approved for use in the United States and certain other regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Tursi, A (2009). Balsalazide in treating colonic diseases. <i>Expert opinion on drug metabolism &amp; toxicology</i> 5(12) 1555â€“1563. DOI:<a href=\"https://doi.org/10.1517/17425250903228842\">10.1517/17425250903228842</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19708827/\">https://pubmed.ncbi.nlm.nih.gov/19708827</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Balsalazide;
